Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database

OBJECTIVE: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. PATIENTS AND METHODS: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was performed using deidentified administrative claims data...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mayo Clin Proc Innov Qual Outcomes
Autori principali: Hasan Albitar, Hasan Ahmad, Van Houten, Holly, Sangaralingham, Lindsey R., Knoedler, Meghan, Almodallal, Yahya, Alkurashi, Adham K., De Moraes, Alice Gallo, Cajigas, Hector, DuBrock, Hillary, Warad, Deepti, Demirel, Nadir, Krowka, Michael, Brinjikji, Waleed, Iyer, Vivek N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930864/
https://ncbi.nlm.nih.gov/pubmed/33718784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2020.08.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi